Syntax Research’s Globus Medical GMED Stock Holding History

Syntax Research’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79K	Hold	1,000	–	–	0.06%	81
2026 Q1	$86.2K	Hold	1,000	–	–	0.05%	82
2025 Q4	$87.3K	Hold	1,000	–	–	0.05%	83
2025 Q3	$57.3K	Hold	1,000	–	–	0.04%	90
2025 Q2	$59K	Hold	1,000	–	–	0.04%	83
2025 Q1	$73.2K	Hold	1,000	–	–	0.05%	83
2024 Q4	$82.7K	Hold	1,000	–	–	0.06%	77
2024 Q3	$71.5K	Hold	1,000	–	–	0.05%	80
2024 Q2	$68.5K	Hold	1,000	–	–	0.05%	74
2024 Q1	$53.6K	Hold	1,000	–	–	0.04%	86
2023 Q4	$53.3K	Hold	1,000	–	–	0.04%	84
2023 Q3	$49.6K	Buy	+1,000	New	+$55.9K	0.04%	88

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Syntax Research's GMED Position: Q2 2026 in Review

Syntax Research held its Globus Medical (GMED) position steady in Q2 2026 at 1,000 shares worth $79K. The position accounts for 0.06% of the portfolio, ranked #81.

Syntax Research first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $87.3K in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Syntax Research held 1,000 shares of Globus Medical worth $79K as of Q2 2026.
Syntax Research left its Globus Medical share count unchanged in Q2 2026.
Globus Medical made up 0.06% of Syntax Research's portfolio in Q2 2026, its #81 holding.
Syntax Research first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
Syntax Research's Globus Medical position peaked at $87.3K in Q4 2025.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.